Cagrilintide 10mg – Driada Medical

153.00

Cagrilintide 10mg – Driada Medical is a peptide designed to reduce body fat, control appetite, and lower the risk of diabetes. This medication activates amylin receptors, which regulate satiety and gastric emptying rate.

Description

Its mechanism of action differs from that of GLP-1 receptor agonists (such as semaglutide, tirzepatide, or retatrutide), so it can be purchased and combined with these for more effective weight loss, especially if other medications have lost their effectiveness and are no longer working. It is also effective on its own at low doses, particularly if you need to preserve as much muscle mass as possible.

Reviews

There are no reviews yet.

Be the first to leave your review on “Cagrilintide 10mg – Driada Medical”
  • Shipping fee from this warehouse: 25 € (25 $)
    If your order includes products from other warehouses, you will be charged additional shipping costs. We therefore advise you to limit the number of warehouses to limit shipping costs.
  • Brands available in this warehouse: Driada-Medical
  • Shipping to Czech Republic, Austria, Belgium, Netherlands, Spain, Italy, Germany, Hungary, France, Luxembourg, Portugal, Greece. NO shipping outside Europe and to Finland, Sweden, Poland, Ireland, Switzerland, Denmark, United Kingdom, Russia, Norway.
  • Shipped from: Europe
  • Payment vaidation : 24 to 72 hours (excluding weekends) after sending your proof of payment.
  • Package preparation and shipping: less than 72 hours (excluding weekends) after the validation of your payment.
  • Transit and delivery: 4-7 days for Europe and 8-10 days for France.
  • Shipping confirmation email (tracking number): 2 days after the parcel is dispatched.
  • You receive your items in a discreet package that has nothing to do with the actual content of your order, without stickers, logos or other marks that could make you guess the content of the package. The name upsteroid or steroid will NOT appear on your package, your bank account, or any invoices or statements.